KR920005714A - 치료제 - Google Patents
치료제 Download PDFInfo
- Publication number
- KR920005714A KR920005714A KR1019910007829A KR910007829A KR920005714A KR 920005714 A KR920005714 A KR 920005714A KR 1019910007829 A KR1019910007829 A KR 1019910007829A KR 910007829 A KR910007829 A KR 910007829A KR 920005714 A KR920005714 A KR 920005714A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- group
- compound
- formula
- guanidino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/16—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C261/00—Derivatives of cyanic acid
- C07C261/04—Cyanamides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/38—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atom of at least one amino group being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfones
- C07C317/42—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
- C07C323/44—X or Y being nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (32)
- 일반식(Ⅰ)의 화합물 및 이의 약제학적으로 허용가능한 염.
-
- 상기식에서, R1은 할로, 탄소수 1내지 3의 알킬, 탄소수 1내지 3의 알콕시, 탄소수 2내지 4의 알카노일, 또는 일반식 S(O)nR8(여기에서, n은 0또는 1이고 R8은 탄소수 1내지 3의 알킬 그룹이다)의 그룹에 의해 임의로 치환된 페닐이고; R2는 탄소수 1내지 4의 직쇄 또는 측쇄 알킬 그룹, 탄소수 3내지 7의 사이클로알킬 그룹, 또는
- 일반식(여기에서, R6및R7은 동일하거나 상이하며, 수소이거나, 탄소수 1내지 4의 알킬 그룹이다)의 그룹이고; R3은 수소이거나 탄소수 1내지 4의 직쇄 지방족 그룹이고; R4는 (a)수소이거나, (b)하이드록시 또는 아실화 유도체, 탄소수 1내지 3의 알콕시 그룹, 탄소수 1내지 3의 알킬티오 그룹, 임의로 알킬화된 아미노 그룹, 탄소수 3내지 7의 카보사이클릭 그룹, 피리딜, 또는 시아노에 의해 임의로 치환된 탄소수 1내지 6의 직쇄 또는 측쇄 지방족 그룹이거나, (c) 하이드록시에 의해 임의로 치환된 탄소수 3내지 7의 카보시아클릭환이며; 이때 단, R1이 페닐인 경우, R3,R4,R6및 R7은 모두 메틸이 아니거나; 그룹 R2와 그룹 R3가 이들과 결합된 탄소원자 및 질소원자와 함께는 일반식
-
- (여기에서, R4,R9및 R10은 동일하거나 상이하며, 수소이거나 탄소수 1내지 4의 알킬 그룹이고, D는 탄소수 1내지 3의 1개 이상의 알킬 그룹에 의해 임의로 치환된 탄소수 2내지 5의 알킬렌 그룹이다)의 헤테로사이클릭 환을 형성하거나, 그룹R2와 그룹R3가 이들과 결합된 탄소원자 및 질소원자와 함께는 일반식
-
- (여기에서. R4는 상기에서 정의한 바와 같으나, 단 R4는 수소가 될 수 없으며, R11은 수소이거나 탄소수 또는 2의 알킬 그룹이고, E는 탄소수 1내지 3의 1개 이상의 알킬 그룹에 의해 임의로 치환된 탄소수 2내지 4의 알킬렌 그룹이다)의 헤테로사이클릭 환을 형성하거나; 그룹 R3와 그룹 R4가 이들과 결합된 질소원자와 함께는 일반식{여기에서, G는 (a)탄소수 3내지 7의 카보사이클릭 환, (b)메틸설포닐 그룹, 또는 (c)하이드록시, 또는 탄소수 1내지 3의 알콕시 그룹에 의해 임의로 치환된 탄소수 1내지 3의 알킬그룹에 의해 임의로 치환된 산소, 황, 설피닐, 설포닐 또는 질소에 의해 임의로 차단되고, 또한 (a)하이드록시에 의해 임의로 치환된 탄소수 그룹, (d)옥소 또는 이의 유도체(예를 들면, 옥심 또는 옥심 에테르), 또는 (e)1개 이상의 일반식 S(O)mR8(여기에서, m은 0또는 1이고, R8은 탄소수 1내지 3의 알킬 그룹이다)의 그룹에 의해 임의로 치환된 탄소수 4내지 6의 알킬렌 그룹이다)의 헤테로사이클릭 환을 형성하거나; R5는 수소이거나, 할로, 탄소수 1내지 4의 알킬 그룹, 탄소수 1내지 3의 알콕시 그룹, 트리플루오로메틸, 및 일반식 S(O)mR8(여기에서, m은 0,1또는 2이고, R8은 탄소수 1내지 3의 알킬 그룹이다)의 그룹중에서 선택된 1개 이상의 임의의 치환체이다.
- 제 1 항에 있어서, R1이 페닐, 2-플루오로페닐, 3-플루오로페닐, 4-플루오로페닐, 4-클로로페닐, 4-메톡시페닐, 3-메틸페닐, 4-메틸페닐, 3-메틸티오페닐, 3-메탄설포닐페닐, 4-메탄설포닐페닐 또는 4-아세틸페닐인 일반식(Ⅰ)의 화합물.
- 제1항 또는 제2항에 있어서, R2가 탄소수 1내지 5의 알킬 그룹, 사이클로헥실, 또는 일반식(Ⅱ)(여기에서, R6및 R7은 독립적으로 수소 또는 메틸이다)의 그룹인 일반식(Ⅰ)의 화합물.
- 제1항 내지 제3항중 어느 한 항에 있어서, 그룹 R3가 수소이거나 탄소수 1내지 3의 알킬 그룹이고; 그룹 R4는 (a)수소이거나, (b)메톡시, 피리딜 또는 디메틸아미노에 의해 임의로 치환된 탄소수 1내지 3의 알킬 그룹이거나, (c)하이드록시에 의해 치환된 페닐 그룹인 일반식(Ⅰ)의 화합물.
- 제1항 또는 제2항에 있어서, (a)R9및 R10이 동일하거나 상이하며, 수소이거나 탄소수 1내지 3의 알킬그룹이고, D는 -(CH2)3-이며, 그룹 R4는 수소이거나; (b)E가 -(CH)2)2-이고, R11은 수소 또는 메틸이고, R4는 메틸, n-부틸 또는 2-하이드록시에틸인 일반식(Ⅰ)의 화합물.
- 제 5 항에 있어서, 일반식(Ⅲ)이 2-피페리디닐리덴이고, 일반식(Ⅳ)는 1-메틸-2-이미다졸리디닐리덴, 1-(n-부틸)-2-이미다졸리디닐리덴, 1-(2-하이드록시에틸)-2-이미다졸리디닐리덴 또는 1,3-디메틸-2-이미다졸리디닐리덴인 일반식(Ⅰ)의 화합물.
- 제1항 내지 제3항 중 어느 한 항에 있어서, G가-(CH2)4-, -(CH2)5-, -CH2-CH=CH-(CH2)2-, -(CH2)2O(CH2)2-, -(CH2)2OCHMeCH2-, -CMe2CH2O(CH2)2-, -(CH2)2S(CH2)-, -(CH2)2SO(CH2)2-, -(CH2)2SO2(CH2)2-, -(CH2)2NMe(CH2)2-, -(CH2)2NEt(CH2)2-, -(CH2)2N(SO2Me)(CH2)2-, -(CH2)2N(CH2CH2OH)(CH2)2-, -(CH2)2CHMe(CH2)2-, -CH2CH(OH)(CH2)2-, -CH2CH(OH)(CH2)3-, -CH2CH(CH2OH)(CH2)3-, -(CH2)2CH(CH2OH)(CH2)2-, -(CH2)2CH(OH)(CH2)2-, -(CH2)2C(OH))Me)(CH2)2-, -(CH2)2CH(OMe)(CH2)2-, -CH2CH(OMe)(CH2)3-, -(CH2)2CH(CONMe2)(CH2)2-, -(CH2)2CO(CH2)2-, -(CH2)2C=NOH(CH2)2-및-(CH2)2C=NOMe(CH2)2-중에서 선택된 그룹인 일반식(Ⅰ)의 화합물.
- 제1항 내지 제3항중 어느 한 항에 있어서, 그룹 -NR3R4가 3-하이드록시-1-피롤리디닐, 피페리디노, 1,2,5,6-데트라하이드로피리딜, 4-메틸피페리디노, 3-하이드록시 피페리디노, 4-하이드록시피페리디노, 4-하이드록시-4-메틸피페리디노, 3-메톡시피페리디노, 4-메톡시피페리디노, 3-하이드록시메틸피페리디노, 4-하이드록시메틸피페리디노, 4-디메틸카바모일피페리디노, 4-피페리디논-1-일, 4-피페리디논-1-일옥심, 4-피페리디논-1-일 옥심-0-메틸 에테르, 모르폴리노, 2-메틸모르폴리노, 3,3-디메틸모르폴리노, 티오모르폴리노, 티오모르폴리노-1-옥사이드, 티오모르폴리노-1, 1-디옥사이드, 4-메틸-1-피페라지닐, 4-에틸-1-피페라지닐, 4-(2-하이드록시에틸)-1-피페라지닐, 및 4-메틸설포닐-1-피페라지닐인 일반식(Ⅰ)의 화합물.
- 제1항 또는 제2항에 있어서, 그룹 -N=C(R2)NR3R4가 N-메틸피발아미디노, 사이클로헥산카복스아미디노, N,N-디메틸구아니디노, N,N'-디메틸구아니디노, N-메틸-N-(2-피리딜에틸)구아니디노, N-에틸-N-(2-메톡시에틸)구아니디노, N-메틸-N-(2-디메틸아미노에틸)구아니디노, N-(4-하이드록시페닐)-N-메틸구아니디노, N,N-(3-옥사펜타메틸렌)구아니디노, N,N-(2-메틸-3-옥사펜타메틸렌)구아니디노, N,N-(1,1-디메틸-3-옥사펜타메틸렌)구아니디노, N,N-(3-티아펜타메틸렌)구아니디노, N,N-(3-티아펜타메틸렌)구아니디노 S-옥사이드, N,N-(3-티아펜타메틸렌)구아니디노 S,S-옥사이드, N,N-(3-메틸-아자펜타메틸렌)구아니디노, N,N-(3-에틸-아자펜타메틸렌)구아니디노, N,N-〔3-(2-하이드록시에틸)-3-아자펜타메틸렌〕구아니디노, N,N-(3-메틸설포닐-3-아자펜타메틸렌)구아니디노, N,N-(2-하이드록시테트라메틸렌)구아니디노, N,N-펜타메틸렌구아니디노, N,N-(2-펜테닐렌)구아니디노, N,N-(3-메틸펜타메틸렌)구아니디노, N,N-(2-하이드록시펜타메틸렌)구아니디노, N,N-(3-하이드록시펜타메틸렌)구아니디노, N,N-(3-하이드록시-3-메틸펜타메틸렌)구아니디노, N,N-(2-하이드록시메틸펜타메틸렌)구아니디노, N,N-(3-하이드록시메틸펜타메틸렌)구아니디노, N,N-(3-디메틸카바모일펜타메틸렌)구아니디노, N,N-(2-메톡시펜타메틸렌)구아니디노, N,N-(3-메톡시펜타메틸렌)구아니디노, N,N-(3-옥소펜타메틸렌)구아니디노, N,N-(3-하이드록시이미노펜타메틸렌)구아니디노, 또는 N,N-(3-메톡시이미노펜타메틸렌)구아니디노인 일반식(Ⅰ)의 화합물.
- 제1항 내지 제9항중 어느 한 항에 있어서, R5가 플루오로, 메틸, 메톡시 및 메틸티오중에서 선택된 1개 이상의 치환체인 일반식(Ⅰ)의 화합물.
- 제1항 내지 제10항중 어느 한 항에 따른 일반식(Ⅰ)의 화합물 치료학적 유효량을 약제학적으로 허용가능한 희석제 또는 담체와 함께 함유하는 약제학적 조성물.
- A)일반식(Ⅳ)의 아미노페닐 화합물을 축합제의 존재하에서 일반식 R2CONR3R4의 아미드 또는 우레아와 반응시키거나, B) 일반식(Ⅵ)의 아미노페닐 화합물(임의로는 염형태의)을 일반식 R2CN의 시아노 화합물과 반응시켜 NR3R4가 NH2인 일반식(Ⅰ)의 화합물을 수득하거나; C)일반식(Ⅳ)의 아미노페닐 화합물(임의로는 염형태의)을 일반식 R3R4NCN의 시안아미드 화합물과 반응시켜 R2가 NH2인 일반식(Ⅰ)의 화합물을 수득하거나; D) 일반식(ⅩⅣ)의 화합물을 일반식NHR3R4의 아민과 반응시켜 R2가 NH2인 일반식(Ⅰ)의 화합물을 수득하거나; E)일반식(ⅩⅡ)의 화합물을 NHR3R4의 아민과 반응시켜 R2가 NR6R7인 일반식(Ⅰ)의 화합물을 수득하는 단계를 특징으로 하여, 일반식(Ⅰ)의 화합물 및 이의 약제학적으로 허용가능한 염을 제조하는 방법.
-
- 상기식에서, R1은 할로, 탄소수 1내지 3의 알킬, 탄소수 1내지 3의 알콕시, 탄소수 2내지 4의 알카노일, 또는 일반식 S(O)nR8(여기에서, n은 0또는 1이고 R8은 탄소수 1내지 3의 알킬 그룹이다)의 그룹에 의해 임의로 치환된 페닐이고; R2는 탄소수 1내지 4의 직쇄 또는 측쇄 알킬 그룹, 탄소수 3내지 7의 사이클로알킬 그룹, 또는
- 일반식(여기에서, R6및 R7은 동일하거나 상이하며, 수소이거나, 탄소수 1내지 4의 알킬 그룹이다)의 그룹이고; R3은 수소이거나 탄소수 1내지 4의 직쇄 또는 측쇄 지방족 그룹이고; R4는 (a)수소이거나, (b)하이드록시 또는 아실화 유도체, 탄소수 1내지 3의 알콕시 그룹, 탄소수 1내지 3의 알킬티오 그룹, 임의로 알칼화 된 아미노 그룹, 탄소수 3내지 7의 카보사이클릭 그룹, 피리딜, 또는 시아노에 의해 임의로 치환된 탄소수 1내지 6의 직쇄 또는 측쇄 지방족 그룹이거나, (c)하이드록시에 의해 임의로 치환된 3내지 7의 카보사이클릭환이며; 이때 단, R1이 페닐인 경우, R3,R4,R6및 R7은 모두 메틸이 아니거나; 그룹 R2와 그룹 R3가 이들과 결합된 탄소원자 및 질소원자와 함께는 일반식
-
- (여기에서, R4,R9및 R10은 동일하거나 상이하며, 수소이거나 탄소수 1내지 4의 알킬 그룹이고, D는 탄소수 1내지 3의 1개 이상의 알킬 그룹에 의해 임의로 치환된 탄소수 2내지 5의 알킬렌 그룹이다)의 헤테로사이클릭 환을 형성하거나, 그룹R2와 그룹R3가 이들과 결합된 탄소원자 및 질소원자와 함께는 일반식
-
- (여기에서. R4는 상기에서 정의한 바와 같으나, 단 R4는 수소가 될 수 없으며, R11은 수소이거나 탄소수 1또는 2의 알킬 그룹이고, E는 탄소수 1내지 3의 1개 이상의 알킬 그룹에 의해 임의로 치환된 탄소수 2내지 4의 알킬렌그룹이다)의 헤테로사이클릭 환을 형성하거나; 그룹 R3와 그룹 R4가 이들과 결합된 질소원자와 함께는 일반식{여기에서, G는 (a)탄소수 3내지 7의 카보사이클릭 환, (b)메틸설포닐 그룹, 또는 (c)하이드록시, 또는 탄소수 1내지 3의 알콕시 그룹에 의해 임의로 치환된 탄소수 1내지 3의 알킬그룹에 의해 임의로 치환된 산소, 황, 설피닐, 설포닐 또는 질소에 의해 임의로 차단되고, 또한 (a)하이드록시에 의해 임의로 치환된 탄소수 1내지 3의 1개 이상의 알킬 그룹, (b)1개 이상의 하이드록시 그룹 또는 이의 에스테르, (c)1개 이상의 알콕시 그룹, (d)옥소 또는 이의 유도체(예를 들면, 옥심 또는 옥심 에테르), 또는 (e)1개 이상의 일반식 S(O)mR8(여기에서, m은 0또는 1이고, R8은 탄소수 1내지 3의 알킬 그룹이다)의 그룹에 의해 임의로 치환된 탄소수 4내지 6의 알킬렌 그룹이다)의 헤테로사이틀릭 환을 형성하거나; R5는 수소이거나, 할로, 탄소수 1내지 4의 알킬 그룹, 탄소수 1내지 3의 알콕시 그룹, 트리플루오로메틸, 및 일반식 S(O)mR8(여기에서, m은 0,1또는 2이고, R8은 탄소수 1내지 3의 알킬 그룹이다)의 그룹중에서 선택된 1개 이상의 임의의 치환체이고; R14는 그룹 R6이고; R15는 그룹 R7이다.
- 제1항 내지 제10항중 어느 한 항에 따른 일반식(Ⅰ)의 화합물을 필요로 하는 환자에게 상기한 화합물을 치료학적 유효량을 투여함을 특징으로 하여 과혈당증을 치료하는 방법.
- 당뇨병을 치료하는데 사용하기 위한, 제1항 내지 제10항중 어느 한 항에 따른 일반식(Ⅰ)의 화합물의 용도.
- 과혈당증을 치료하는데 사용하기 위한, 제1항 내지 제10항중 어느 한 항에 따른 일반식(Ⅰ)의 화합물의 용도.
- 당뇨병 치료용 약제를 제조하는데 사용하기 위한, 제1항 내지 제10항중 어느 한 항에 따른 일반식(Ⅰ)화합물의 용도.
- 과혈당증 치료용 약제를 제조하는데 사용하기 위한, 제1항 내지 제10항중 어느 한 항에 따른 일반식(Ⅰ)화합물의 용도.
- ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN126BO1990 IN172842B (ko) | 1990-05-17 | 1990-05-17 | |
IN126/80M190 | 1990-05-17 | ||
GB90/144569 | 1990-06-28 | ||
GB909014456A GB9014456D0 (en) | 1990-06-28 | 1990-06-28 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
KR920005714A true KR920005714A (ko) | 1992-04-03 |
Family
ID=26297257
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019910007829A KR920005714A (ko) | 1990-05-17 | 1991-05-15 | 치료제 |
Country Status (27)
Country | Link |
---|---|
US (1) | US5302720A (ko) |
EP (1) | EP0536151B1 (ko) |
JP (1) | JPH089589B2 (ko) |
KR (1) | KR920005714A (ko) |
CN (1) | CN1028521C (ko) |
AT (1) | ATE111445T1 (ko) |
AU (1) | AU637695B2 (ko) |
BG (1) | BG61260B1 (ko) |
CA (1) | CA2041846A1 (ko) |
CZ (1) | CZ280182B6 (ko) |
DE (1) | DE69104041T4 (ko) |
DK (1) | DK0536151T3 (ko) |
ES (1) | ES2064103T3 (ko) |
FI (1) | FI95566C (ko) |
GB (1) | GB2244486B (ko) |
HR (1) | HRP930699A2 (ko) |
HU (1) | HU210200B (ko) |
IE (1) | IE64485B1 (ko) |
IL (1) | IL98029A (ko) |
IN (1) | IN172842B (ko) |
MX (1) | MX25770A (ko) |
NO (1) | NO179204C (ko) |
NZ (1) | NZ238119A (ko) |
PL (1) | PL167657B1 (ko) |
PT (1) | PT97700B (ko) |
RU (1) | RU2099323C1 (ko) |
WO (1) | WO1992000273A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990017013A (ko) * | 1997-08-20 | 1999-03-15 | 윤종용 | 가변단속주기의 오디오신호 발생장치 |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004054A1 (en) * | 1990-08-30 | 1992-03-19 | STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of THE OREGON HEALTH SCIENCES UNIVERSITY, PORTLAND, OREGON, and THE UNIVERSITY OF OREGON, EUGENE, OREGON, Johnson Hall, University of Oregon | Substituted amidines having high binding to the sigma receptor and the use thereof |
US5298657A (en) * | 1992-03-20 | 1994-03-29 | Cambridge Neuroscience Inc. | Preparation of substituted guanidines |
ATE180255T1 (de) * | 1993-03-23 | 1999-06-15 | Astra Ab | Guanidinderivate mit therapeutischer wirkung |
US5512596A (en) * | 1994-09-02 | 1996-04-30 | Gilead Sciences, Inc. | Aromatic compounds |
WO1996017612A1 (en) * | 1994-12-08 | 1996-06-13 | Knoll Aktiengesellschaft | Use of substituted phenylamidine and phenylguanidine compounds for the treatment of cerebral and cardiac ischaemia, convulsion and sickle cell anaemia |
ES2164990T3 (es) * | 1996-04-30 | 2002-03-01 | Pfizer | Agonistas de receptores muscarinicos. |
US6756389B2 (en) * | 1996-08-09 | 2004-06-29 | Cambridge Neuroscience, Inc. | Pharmaceutically active compounds and methods of use |
DE19737463A1 (de) * | 1997-08-28 | 1999-03-04 | Hoechst Marion Roussel De Gmbh | Verwendung von Inhibitoren des Natrium-Wasserstoff-Austauschers zur Herstellung eines Arzneimittels zur Behandlung von Erkrankungen, die durch Protozoen verursacht werden |
EP1083822A4 (en) | 1998-06-11 | 2005-10-12 | S P O Medical Equipment Ltd | DEVICE FOR DETECTING PHYSIOLOGICAL STRESS AND RELATED METHOD |
US7176228B2 (en) * | 2000-07-24 | 2007-02-13 | Bayer Cropscience Ag | Pyrazole biphenylcarboxamides |
IL153929A0 (en) | 2000-07-24 | 2003-07-31 | Bayer Cropscience Ag | Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
DE10258314A1 (de) * | 2002-12-13 | 2004-06-24 | Bayer Cropscience Ag | Biphenyloximether |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
JP5213711B2 (ja) | 2005-09-13 | 2013-06-19 | バイエル・クロップサイエンス・アーゲー | 殺有害生物剤チアゾリルオキシ置換フェニルアミジン誘導体 |
CN104945287B (zh) * | 2015-06-12 | 2017-06-13 | 苏州大学张家港工业技术研究院 | 一种脒的磺酸内盐化合物的合成方法 |
AR101498A1 (es) * | 2015-08-11 | 2016-12-21 | Chemo Res S L | Procedimiento para la preparación del compuesto n-(3,5-dimetilfenil)-n-(2-trifluorometilfenil)guanidina y su forma cristalina a |
GB201809295D0 (en) | 2018-06-06 | 2018-07-25 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
GB201818750D0 (en) | 2018-11-16 | 2019-01-02 | Institute Of Cancer Res Royal Cancer Hospital | Lox inhibitors |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1850682A (en) * | 1927-01-10 | 1932-03-22 | Ig Farbenindustrie Ag | Substituted guanidines |
GB614072A (en) * | 1946-07-01 | 1948-12-09 | Boots Pure Drug Co Ltd | Manufacture of phenanthridine compounds |
NL299929A (ko) * | 1962-10-30 | |||
US3252982A (en) * | 1963-10-16 | 1966-05-24 | Ciba Geigy Corp | Benzhydryl compounds |
US3669974A (en) * | 1971-03-25 | 1972-06-13 | Usv Pharma Corp | N,n1-disubstituted benzamidines |
BE788767A (fr) * | 1971-09-13 | 1973-01-02 | Richardson Merrell Inc | Compositions hypoglycemiques contenant des derives de benzhydryllactamimide |
FR2223361B1 (ko) * | 1973-03-27 | 1977-04-29 | Philagro Sa | |
DE2417669A1 (de) * | 1974-04-11 | 1975-10-16 | Hoechst Ag | Verfahren zur herstellung von n(halogenaryl)-n',n'-dialkylamidinen |
US4061746A (en) * | 1976-04-23 | 1977-12-06 | Richardson-Merrell Inc. | Lactamimide inhibitors of gastrointestinal hypersecretion |
JPS604829B2 (ja) * | 1977-03-28 | 1985-02-06 | 日本曹達株式会社 | イミダゾール誘導体、その製造方法及び農園芸用殺菌剤 |
US4101659A (en) * | 1977-08-29 | 1978-07-18 | Mcneil Laboratories, Incorporated | Benzhydryl guanidines |
US4414211A (en) * | 1978-09-18 | 1983-11-08 | Mcneilab, Inc. | Heterocyclic derivatives of guanidine |
NL7810350A (nl) * | 1978-10-16 | 1980-04-18 | Duphar Int Res | Preparaat met groeiregulerende werking en gebruik van dit preparaat in land- en tuinbouw. |
ZA801680B (en) * | 1979-04-03 | 1981-03-25 | Fujisawa Pharmaceutical Co | 2-imidazoline derivatives,process for the preparation thereof and the pharmaceutical composition of the same |
AU538963B2 (en) * | 1979-07-09 | 1984-09-06 | Seth Thomas Shaw Jr. | Drug for use with an iud |
US4281004A (en) * | 1980-03-31 | 1981-07-28 | Pfizer Inc. | Phenylguanidine therapeutic agents |
DE3108564A1 (de) * | 1981-03-06 | 1982-11-18 | Bayer Ag, 5090 Leverkusen | N-tert-butyl-phenyl-n'-cyclohexyl-quanidine, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
ATE19880T1 (de) * | 1981-08-24 | 1986-06-15 | Merck & Co Inc | Thiadiazole oxyde mit antisekretorischer wirkung. |
DE3220828A1 (de) * | 1982-06-03 | 1983-12-08 | Hoechst Ag, 6230 Frankfurt | Bisamidin-derivate von dephenyl, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
IN158084B (ko) * | 1982-06-25 | 1986-08-30 | Council Scient Ind Res | |
DE3343815A1 (de) * | 1983-12-03 | 1985-06-13 | Hoechst Ag, 6230 Frankfurt | Neue bisamidindiphenylderivate, ein verfahren zu ihrer herstellung und ihre verwendung als chemotherapeutika |
US4680300A (en) * | 1985-01-10 | 1987-07-14 | Syntex (U.S.A.) Inc. | Anti-inflammatory guanidines |
US4656270A (en) * | 1985-03-15 | 1987-04-07 | Mcneilab, Inc. | Process for producing guanidines such as linogliride |
US4693850A (en) * | 1985-03-15 | 1987-09-15 | Mcneilab, Inc. | Methane sulfonic acid derivatives |
US4781866A (en) * | 1985-03-15 | 1988-11-01 | Mcneilab, Inc. | Process for producing amidine sulfonic acid intermediates for guanidines |
SG47583A1 (en) * | 1986-01-13 | 1998-04-17 | American Cyanamid Co | 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines |
US4709094A (en) * | 1986-07-10 | 1987-11-24 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon | Sigma brain receptor ligands and their use |
GB8903592D0 (en) * | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
IE62023B1 (en) * | 1989-01-02 | 1994-12-14 | Boots Co Plc | Therapeutic agents |
DE3922232A1 (de) * | 1989-07-06 | 1991-01-17 | Basf Ag | Fungizide guanidine |
EP0418199A3 (en) * | 1989-09-13 | 1991-06-12 | Ciba-Geigy Ag | Guanidine derivatives |
-
1990
- 1990-05-17 IN IN126BO1990 patent/IN172842B/en unknown
-
1991
- 1991-04-29 IE IE143991A patent/IE64485B1/en not_active IP Right Cessation
- 1991-05-02 IL IL9802991A patent/IL98029A/en active IP Right Grant
- 1991-05-06 CA CA002041846A patent/CA2041846A1/en not_active Abandoned
- 1991-05-07 AU AU76394/91A patent/AU637695B2/en not_active Ceased
- 1991-05-07 CZ CS911334A patent/CZ280182B6/cs not_active IP Right Cessation
- 1991-05-10 NZ NZ238119A patent/NZ238119A/en unknown
- 1991-05-13 GB GB9110306A patent/GB2244486B/en not_active Expired - Fee Related
- 1991-05-14 MX MX25770A patent/MX25770A/es unknown
- 1991-05-15 DE DE69104041A patent/DE69104041T4/de not_active Expired - Fee Related
- 1991-05-15 KR KR1019910007829A patent/KR920005714A/ko not_active Application Discontinuation
- 1991-05-15 DK DK91909161.1T patent/DK0536151T3/da active
- 1991-05-15 PL PL91297374A patent/PL167657B1/pl unknown
- 1991-05-15 ES ES91909161T patent/ES2064103T3/es not_active Expired - Lifetime
- 1991-05-15 WO PCT/EP1991/000911 patent/WO1992000273A1/en active IP Right Grant
- 1991-05-15 JP JP3508950A patent/JPH089589B2/ja not_active Expired - Lifetime
- 1991-05-15 RU RU9292016545A patent/RU2099323C1/ru active
- 1991-05-15 AT AT91909161T patent/ATE111445T1/de not_active IP Right Cessation
- 1991-05-15 EP EP91909161A patent/EP0536151B1/en not_active Expired - Lifetime
- 1991-05-16 HU HU911650A patent/HU210200B/hu not_active IP Right Cessation
- 1991-05-16 PT PT97700A patent/PT97700B/pt not_active IP Right Cessation
- 1991-11-14 CN CN91110775A patent/CN1028521C/zh not_active Expired - Fee Related
-
1992
- 1992-06-17 US US07/899,939 patent/US5302720A/en not_active Expired - Fee Related
- 1992-12-10 NO NO924783A patent/NO179204C/no unknown
- 1992-12-22 BG BG97221A patent/BG61260B1/bg unknown
- 1992-12-23 FI FI925871A patent/FI95566C/fi active
-
1993
- 1993-04-02 HR HR930699A patent/HRP930699A2/hr not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR19990017013A (ko) * | 1997-08-20 | 1999-03-15 | 윤종용 | 가변단속주기의 오디오신호 발생장치 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920005714A (ko) | 치료제 | |
NO900991D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(l-piperazinyl)-4-fenylcycloalkanopyridin-derivater | |
NZ518144A (en) | Piperazine Compounds | |
KR940005534A (ko) | 아릴글리신아미드 유도체, 이의 제조방법 및 활성성분으로서 이를 함유하는 배뇨 장해 치료제 | |
SE9703377D0 (sv) | New compounds | |
DE60011462D1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
PT1468692E (pt) | Utilizacao de 2,6-dialquil-4-sililfenois para o tratamento do xantoma | |
ATE117303T1 (de) | Imidazo(1,2-c>chinazolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen. | |
GB1421970A (en) | 8-azapurin-6-one derivatives | |
KR910004559A (ko) | 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환 아미노)-2-부티닐-1-우레아 및 티오우레아와 그의 유도체 | |
ATE83234T1 (de) | Oxadiazol-pyrimidinone, ihre herstellung und ihre kosmetische und dermopharmazeutische verwendung. | |
DE69618050D1 (de) | Substituierte Benzylthienylpiperazine, ihre Anwendung als Arzneimittel und Verfahren für ihre Herstellung | |
SE8005343L (sv) | Forfarande for vegning av hudar och skinn | |
KR910004550A (ko) | 중추 신경계에 작용하는 무스카린성 약제인 4-(n-치환아미노)-2-부티닐-1-카르바메이트 및 티오카르바메이트와 그의 유도체 | |
IL99390A0 (en) | 3,3-bisthioalkyl-2-pyridylacrylic acid derivatives,methods for the production thereof and fungicidal compositions containing the same | |
NO930068D0 (no) | Nye kjemiske forbindelser | |
ATE82972T1 (de) | Thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
ATE215075T1 (de) | Hydroxylamin-derivate mit anti-ischämischer wirkung und pharmazeutische zusammensetzungen diese enthaltend | |
ZA804643B (en) | Carboxamide vinylogues, processes for their preparation, and pharmaceutical compositions containing them | |
KR900003141A (ko) | 신규한 벤즈아졸 유도체, 이의 제조방법과 이러한 화합물들을 함유하는 약학적 제제 및 이의 용도 | |
KR890002195A (ko) | 신규 2'-치환-4- 데옥시- 티아졸로[5,4-c] 리피마이신 SV 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |